000			01990 a2200577 4500
005			20250517021827.0
264		0	_c20150522
008			201505s 0 0 eng d
022			_a1878-3686
024	7		_a10.1016/j.ccell.2015.02.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aWilson, Frederick H
245	0	0	_aA functional landscape of resistance to ALK inhibition in lung cancer. _h[electronic resource]
260			_bCancer cell _cMar 2015
300			_a397-408 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnaplastic Lymphoma Kinase
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCrizotinib
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aErbB Receptors _xgenetics
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aPyrazoles _xpharmacology
650	0	4	_aPyridines _xpharmacology
650	0	4	_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aReceptor, ErbB-2 _xgenetics
650	0	4	_aReceptors, Purinergic P2Y _xgenetics
650	0	4	_aSignal Transduction _xdrug effects
700	1		_aJohannessen, Cory M
700	1		_aPiccioni, Federica
700	1		_aTamayo, Pablo
700	1		_aKim, Jong Wook
700	1		_aVan Allen, Eliezer M
700	1		_aCorsello, Steven M
700	1		_aCapelletti, Marzia
700	1		_aCalles, Antonio
700	1		_aButaney, Mohit
700	1		_aSharifnia, Tanaz
700	1		_aGabriel, Stacey B
700	1		_aMesirov, Jill P
700	1		_aHahn, William C
700	1		_aEngelman, Jeffrey A
700	1		_aMeyerson, Matthew
700	1		_aRoot, David E
700	1		_aJänne, Pasi A
700	1		_aGarraway, Levi A
773	0		_tCancer cell _gvol. 27 _gno. 3 _gp. 397-408
856	4	0	_uhttps://doi.org/10.1016/j.ccell.2015.02.005 _zAvailable from publisher's website
999			_c24696251 _d24696251